Virtus Health Limited (ASX: VRT) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Virtus Health Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • Virtus Health Limited (ASX: VRT)
    Latest News

    No posts found.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    17 Jun 2022 $0.3000 100.00% Special Cash 01 Jul 2022
    23 Mar 2022 $0.1200 100.00% Interim 14 Apr 2022
    08 Oct 2021 $0.1200 100.00% Final 29 Oct 2021
    24 Mar 2021 $0.1200 100.00% Interim 15 Apr 2021
    25 Mar 2020 $0.1200 100.00% Interim 30 Nov 2020
    03 Oct 2019 $0.1200 100.00% Final 25 Oct 2019
    28 Mar 2019 $0.1200 100.00% Interim 18 Apr 2019
    13 Sep 2018 $0.1200 100.00% Final 12 Oct 2018
    28 Mar 2018 $0.1400 100.00% Interim 17 Apr 2018
    14 Sep 2017 $0.0000 100.00% Final 13 Oct 2017
    30 Mar 2017 $0.1300 100.00% Interim 18 Apr 2017
    15 Sep 2016 $0.1500 100.00% Final 14 Oct 2016
    31 Mar 2016 $0.1400 100.00% Interim 15 Apr 2016
    30 Sep 2014 $0.1400 100.00% Final 16 Oct 2014
    31 Mar 2014 $0.1200 100.00% Interim 17 Apr 2014

    VRT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Kate Munnings Chief Executive OfficerExecutive Director Mar 2020
    Ms Munnings has more than 30 years of professional and operational experience. Prior to joining Virtus Health, Kate led operations including as Chief Operating Officer of Ramsay Health Care Limited's 72 Australian hospitals; and as Chief Executive, Operations leading a portfolio of largely government contracts across Australia, New Zealand and Melanesia at Transfield Services Limited.
    Ms Catherine (Cathy) Ann Aston Non-Executive Director Sep 2021
    Ms Aston had an executive career at Telstra where she moved across roles in finance, marketing and strategy, including as the Finance Director of the International Division where she was based in Hong Kong and New Delhi and as Chief Executive of a mobile phone company based in Colombo. Cathy's executive roles each had a focus on enabling the business to improve its customer service and to operate more effectively and efficiently through better use of technology. Since 2013, Cathy has held a range of non-executive director roles and has also worked as a business advisor with a range of clients. Most recently, Cathy has worked with the NSW Government to improve outcomes across an array of programs and is currently a nonexecutive director with Macquarie Investment Management Ltd, IMB Bank Ltd, IVE Group (ASX: IGL) and Over the Wire Holdings (ASX: OTW), with the latter two roles also including Chair of Audit, Risk and Compliance committees. Cathy's non-executive director experience also includes serving as an Advisory Board Member of Avanseus, an AI business based out of Singapore.
    Dr Priscilla Rogers Non-Executive Director Sep 2021
    Dr Rogers has had direct experience in how technology innovation can transform industries and improve lives. She has spent her career in the research, development and translation of new technologies including medical devices, artificial intelligence (AI) and digital health solutions, including leading the Cognitive Health & Life Sciences portfolio at IBM Research Australia. Priscilla is currently a director and co-founder of Doftek, which is commercializing the active wheel alignment systems for vehicles; as well as a director and co-founder of Grean Brands, which is a health and wellness company responsible for developing and commercializing new antimicrobial prevention products. Priscilla previously co-founded IntelliMedical, which developed steerable guide wires for minimally invasive surgical procedures and was acquired by Merit Medical (NASDAQ: MMSI) in 2017. Priscilla's non-executive director roles include serving on the Board of the Digital Health Cooperative Research Centre and the Board of Australian Dementia Network Limited.
    Mr David Brooks Non-Executive Director Jun 2022
    Mr Brooks is a Partner at BGH Capital focused on investments in the Healthcare and Technology sectors. Previously, he was a Principal at TPG based in Melbourne where he spent nine years and was involved in the investments in Healthscope and Inghams, as well as working across the Myer and Asciano portfolio companies. Prior to joining TPG in 2008, he worked in the investment banking division of Credit Suisse for more than three years.
    Mr Joel Aitken Non-Executive Director Jun 2022
    Mr Aitken is a Principal at BGH Capital. Previously, he worked at Nestle based in Switzerland reporting to Nestle's Global Head of Strategy & Business Development. Prior to joining Nestle in 2018, he worked in the investment banking division of UBS in New York and Australia working on M&A, leveraged finance and equity capital markets transactions for ten years.
    Mr Benjamin Gray Non-Executive Director Jun 2022
    Mr Gray is a Founding Partner of BGH Capital. Previously, he was a Managing Partner at TPG, where he served as the Joint Head of Asia, as the Head of Australia and New Zealand and as a member of the Global Management Committee. He spent almost thirteen years at TPG and led investments in Myer, Asciano, Petbarn, Healthscope and Inghams. Prior to joining TPG in 2004, he worked in the investment banking division of Credit Suisse in New York and Australia from 1994.
    Ms Ava Bentley Group General Manager-Legal & RiskCompany Secretary May 2021
    Matthew Prior Chief Financial Officer
    Richard Banks Chief Strategy Officer (CSO) and European Managing Director
    Ava Bentley Group General Manager-Legal & RiskCompany Secretary

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Paradice Investment Mgt 7,431,947 8.70%
    Yarra Capital Mgt 7,374,259 8.60%
    Wilson Asset Mgt 5,292,656 6.20%
    Dimensional Fund Advisors 4,411,125 5.20%
    Vinva Investment Mgt 3,225,895 3.80%
    Merlon Capital Partners 2,434,948 2.80%
    Macquarie Securities 1,905,730 2.20%
    Vanguard Group 1,671,279 2.00%
    Eley Griffiths Group 1,460,714 1.70%
    Auscap Asset Mgt 1,350,000 1.60%
    Realindex Investments 1,309,480 1.50%
    Vanguard Investments Australia 1,285,276 1.50%
    Norges Bank Investment Mgt 1,191,815 1.40%
    Plato Investment Mgt 1,189,534 1.40%
    Acadian Asset Mgt (Australia) 1,113,810 1.30%
    Ausbil Investment Mgt 1,089,050 1.30%
    JPMorgan Securities Australia 965,489 1.10%
    1851 Capital 940,220 1.10%
    Mr Lyndon G Hale 826,572 1.00%
    Ellerston Capital 728,927 0.90%